We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Genetic Locus with Unique Tandem Repeats Linked to Development of Late-onset Alzheimer’s Disease

By LabMedica International staff writers
Posted on 02 Dec 2019
Researchers have discovered evidence of a novel genetic variation linked to the development of late-onset Alzheimer’s disease (AD).

Late-onset Alzheimer’s disease (LOAD) is a common complex disorder of old age. More...
Though these types of disorders can be highly heritable, they differ from single-gene (Mendelian) diseases in that their causes are often multi-factorial with both genetic and environmental components. Genetic risk factors that have been firmly implicated are mutations in the amyloid precursor protein (APP), presenilin 1 (PSEN1) and presenilin 2 (PSEN2) genes, which are found in large multi-generational families with an autosomal dominant pattern of disease inheritance, the apolipoprotein E (APOE) epsilon 4 allele and the sortilin-related receptor (SORL1) gene.

Environmental factors that have been associated with late-onset Alzheimer’s disease include depressive illness, various vascular risk factors, level of education, head trauma, and estrogen replacement therapy. This complexity may help explain their high prevalence from an evolutionary perspective, but the etiologic complexity makes identification of disease-related genes much more difficult. The “endophenotype” approach is an alternative method for measuring phenotypic variation that may facilitate the identification of susceptibility genes for complexly inherited traits.

To identify genetic variations linked to development of LOAD, investigators at the University of Kentucky (Lexington, USA) analyzed Alzheimer's Disease Sequencing Project (ADSP) whole exome sequencing (WES) data derived from over 10,000 individuals.

The locus of interest was a poorly annotated region of the exome (the protein-coding DNA within the genome) with unique tandem repeats, largely unreadable by existing sequencing methods. Therefore, the investigators performed additional studies including PCR-based characterization of the tandem repeat-containing region in a cohort of autopsied individuals. Those results were correlated with LOAD pathological endophenotypes, and augmented by immunohistochemical analyses from LOAD cases and non-AD control brains.

The investigators reported finding evidence of LOAD-linked genetic variation within an exon of the Mucin 6 (MUC6) gene, and approximately 4000 base pairs downstream from another gene that encodes Adaptor Related Protein Complex 2 Subunit Alpha 2 (AP2A2).

PCR analyses on genomic DNA samples confirmed that the size of the MUC6 variable number tandem repeat (VNTR) region was highly polymorphic, and the size of the polymorphic region was associated with the severity of pTau pathology in the neocortex. AP2A2 expression was lower in a subset analysis of brain samples from persons with longer versus shorter VNTR regions, and AP2A2 was often co-localized with neurofibrillary tangles in LOAD.

Senior author Dr. Peter Nelson, professor of neuropathology at the University of Kentucky, said, "Our findings were made in a group of patients that is relatively small for a genetics study - some recent studies included hundreds of thousands of research subjects! That small sample size means two things: first, we should exercise caution and we need to make sure the phenomenon can be replicated in other groups; and second, it implies that there is a very large effect size - the genetic variation is strongly associated with the disease."

The study was published in the November 4, 2019, online edition of the Journal of Neuropathology & Experimental Neurology.

Related Links:
University of Kentucky


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.